The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Hepatitis B and the Need for a Booster Dose
Abstract
After several decades of vaccination against hepatitis B virus in newborns, infants, adolescents, and adults, the question remains whether a booster dose is ever needed. Long-term protection is most commonly measured through 4 methods: the anamnestic response after administration of a booster dose, infection rate in vaccinated populations, in vitro B and T cell activity testing, and seroepidemiological studies. Long-term protection is present despite a decrease in anti-hepatitis B surface antibodies over time. The exact mechanism of long-term protection, however, is not yet fully understood. There is no need for boosters in immunologically potent persons as long as a full course was adequately administered that respected the recommended timelines, as evidenced by studies conducted up to 20 years after the original immunization course. However, a booster dose should be planned for immunocompromised patients, based on serological monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Mast, E. E., Weinbaum, C. M., Fiore, A. E., Alter, M. J., Bell, B. P., Finelli, L., Rodewald, L. E., Douglas, J. M., Janssen, R. S., & Ward, J. W. (2006) · PubMed · Cited by 1,132
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrison, J. M., & Kellner, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031501 · Cited by 1,100
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Are booster immunisations needed for lifelong hepatitis B immunity?
(2000) · The Lancet · doi:10.1016/s0140-6736(99)07239-6 · Cited by 455
West, D. (1996) · Vaccine · doi:10.1016/0264-410x(96)00062-x · Cited by 375
Zanetti, A. R., Mariano, A., Romanò, L., D'Amelio, R., Chironna, M., Coppola, R. C., Cuccia, M., Mangione, R., Marrone, F., Negrone, F. S., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67568-x · Cited by 368
What Level of Hepatitis B Antibody Is Protective?
Jack, A. D., Hall, A. J., Maine, N., Mendy, M., & Whittle, H. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314578 · Cited by 354
Ni, Y., Huang, L., Chang, M., Yen, C., Lu, C., You, S., Kao, J., Lin, Y., Chen, H., Hsu, H., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.055 · Cited by 348
Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up
McMahon, B. J., Bruden, D. L., Petersen, K. M., Bulkow, L. R., Parkinson, A. J., Nainan, O., Khristova, M., Zanis, C., Peters, H., & Margolis, H. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00008 · Cited by 315
Cited by
Vos, M. B., Abrams, S. H., Barlow, S. E., Caprio, S., Daniels, S. R., Kohli, R., Mouzaki, M., Sathya, P., Schwimmer, J. B., Sundaram, S. S., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001482 · Cited by 1,008
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
“1 13 US Department of Health and Human Services/Centers for Disease Control and Prevention dose are considered protected, regardless of subsequent declines in anti-HBs (10,109).”
BackgroundPattyn, J., Hendrickx, G., Vorsters, A., & Van Damme, P. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa668 · Cited by 282
Self-citationScreening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
Conners, E. E., Panagiotakopoulos, L., Hofmeister, M. G., Spradling, P. R., Hagan, L. M., Harris, A. M., Rogers-Brown, J. S., Wester, C., Nelson, N. P., Contributors, et al. (2023) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7201a1 · Cited by 268
Seroprotection after recombinant hepatitis B vaccination among newborn infants: A review
Schillie, S. F., & Murphy, T. V. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.012 · Cited by 105
Metadata
- Authors
- Leuridan, E., & Van Damme, P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-07
- Volume
- 53
- Issue
- 1
- Pages
- 68-75
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2153060595
- Cited by
- 308
- References
- 46
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatitis B and the Need for a Booster Dose. https://app.cochat.ai/papers/10.1093/cid/cir270
- The paper
- Leuridan, E., & Van Damme, P. (2011). Hepatitis B and the Need for a Booster Dose. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cir270
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.